1. Cervarix and the risk of miscarriage

   Clinical study 09 February 2013 Pages: 1 - 1

2. Eltroxin: formulation change cause of ADR increase?

   News item 09 February 2013 Pages: 2 - 2

3. Fluoxetine link to congenital heart disorders

   News item 09 February 2013 Pages: 2 - 2

4. Health Canada is warning consumers that the supposedly herbal product 'POWER-MAX' has been found to contain sildenafil,

   Media release 09 February 2013 Pages: 2 - 2

5. Roche and Biogen Idec have suspended trials of ocrelizumab treatment in patients with rheumatoid arthritis due to safety concerns,

   Media release 09 February 2013 Pages: 2 - 2

6. Bevacizumab and hypertension: a Catch-22?

   Clinical study 09 February 2013 Pages: 3 - 3

7. A homozygous UGT1A1*28 genotype appears to predict grade 3−4 treatment-induced neutropenia in patients receiving irinotecan,

   Clinical study 09 February 2013 Pages: 3 - 3

8. Adalimumab

   Case report 09 February 2013 Pages: 4 - 4

9. Acetic acid

   Case report 09 February 2013 Pages: 4 - 4

10. Adalimumab/etanercept/infliximab

    Case report 09 February 2013 Pages: 4 - 5

11. Alemtuzumab

    Case report 09 February 2013 Pages: 5 - 5

12. Alemtuzumab

    Case report 09 February 2013 Pages: 5 - 5

13. Alendronic acid/pamidronic acid/risedronic acid

    Case report 09 February 2013 Pages: 5 - 6

14. Antineoplastics

    Case report 09 February 2013 Pages: 6 - 6

15. Amiodarone

    Case report 09 February 2013 Pages: 6 - 6

16. Amoxicillin

    Case report 09 February 2013 Pages: 6 - 6

17. Antineoplastics

    Case report 09 February 2013 Pages: 7 - 7

18. Antineoplastics

    Case report 09 February 2013 Pages: 7 - 7

19. Antineoplastics/antivirals

    Case report 09 February 2013 Pages: 8 - 8

20. Antiretrovirals

    Case report 09 February 2013 Pages: 8 - 8

21. Arsenic

    Case report 09 February 2013 Pages: 8 - 8

22. Bevacizumab

    Case report 09 February 2013 Pages: 9 - 9

23. Bevacizumab

    Case report 09 February 2013 Pages: 9 - 9

24. Aspirin

    Case report 09 February 2013 Pages: 9 - 9

25. Bupropion

    Case report 09 February 2013 Pages: 9 - 9

26. Benzathine benzylpenicillin

    Case report 09 February 2013 Pages: 9 - 9

27. Carboplatin/docetaxel

    Case report 09 February 2013 Pages: 10 - 10

28. Cetuximab/erlotinib/panitumumab

    Case report 09 February 2013 Pages: 10 - 10

29. Ciprofloxacin/methadone/venlafaxine interaction

    Case report 09 February 2013 Pages: 11 - 11

30. Cisplatin

    Case report 09 February 2013 Pages: 11 - 11

31. Cisplatin

    Case report 09 February 2013 Pages: 11 - 11

32. Ciprofloxacin/levofloxacin

    Case report 09 February 2013 Pages: 11 - 11

33. Clopidogrel

    Case report 09 February 2013 Pages: 12 - 12

34. Cotrimoxazole

    Case report 09 February 2013 Pages: 12 - 12

35. Clozapine

    Case report 09 February 2013 Pages: 12 - 12

36. Deflazacort

    Case report 09 February 2013 Pages: 13 - 13

37. Dopamine receptor antagonists

    Case report 09 February 2013 Pages: 13 - 13

38. Dexmedetomidine

    Case report 09 February 2013 Pages: 13 - 13

39. Doxycycline

    Case report 09 February 2013 Pages: 13 - 14

40. Duloxetine

    Case report 09 February 2013 Pages: 14 - 14

41. Epinephrine/norepinephrine

    Case report 09 February 2013 Pages: 14 - 14

42. Enbucrilate

    Case report 09 February 2013 Pages: 14 - 14

43. Etanercept

    Case report 09 February 2013 Pages: 15 - 15

44. Etanercept

    Case report 09 February 2013 Pages: 15 - 15

45. Erlotinib

    Case report 09 February 2013 Pages: 15 - 15

46. Ferrous sulfate

    Case report 09 February 2013 Pages: 15 - 16

47. Fluconazole

    Case report 09 February 2013 Pages: 16 - 16

48. Fluorouracil

    Case report 09 February 2013 Pages: 16 - 16

49. Flupentixol/melitracen

    Case report 09 February 2013 Pages: 16 - 17

50. Gemcitabine

    Case report 09 February 2013 Pages: 17 - 17